
Pulse Biosciences Investor Relations Material
Latest events

Q1 2025
Pulse Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pulse Biosciences Inc
Access all reports
Pulse Biosciences Inc. is a medical technology company that develops therapeutic devices based on its proprietary Nano-Pulse Stimulation (NPS) technology. This technology uses short, nanosecond-duration electrical pulses to treat cellular structures, offering potential applications in dermatology, oncology, and other medical fields. Pulse Biosciences' products are designed to provide non-invasive treatment options, with the goal of improving clinical outcomes for patients in various therapeutic areas. The company is headquartered in Hayward, California, and its shares are listed on the NASDAQ.
Key slides for Pulse Biosciences Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Pulse Biosciences Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Pulse Biosciences Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PLSE
Country
🇺🇸 United States